Why Geron, Penn Virginia, and FutureFuel Are Today's 3 Best Stocks

The broad-based S&P 500 (SNPINDEX: ^GSPC  ) soared for a second-straight session after a slew of economic data met expectations and Russian President Vladimir Putin assured the rest of the world that he had no intentions of pressing even further into Ukraine.

Three key pieces of economic data helped fuel the S&P 500's rise, including two reports from the housing industry. In what was a nice departure from the negativity witnessed last month, housing starts for February came in at a seasonally adjusted 907,000, down a fractional 0.2% from January but pretty much in line with wide-ranging estimates. Following a rapid decline in January, this stabilization helped calm the market. In addition, building permits for February surged 7.7% to a seasonally adjusted rate of 1,018,000, signaling that the homebuilding sector is still seeing strong demand amid low inventory levels.

Finally, on the economic data front, the Consumer Price Index rose by 0.1% in February, which is just what economists predicted. Some level of inflation is good since prices naturally tend to rise in an expansionary economy; however, we also don't want prices going through the roof, which is not happening in this case.

Easing geopolitical tensions also helped push the market higher as Russia's leader moved to formally annex Crimea while vowing not to seek additional Ukrainian territory. Despite this reassurance, tension in this region is still so thick you could cut it with a knife, and sanctions imposed on Russia by the United States and European Union could curb growth in Russia and across the globe.

By day's end the S&P 500 had moved decisively higher by 13.42 points (0.72%) to close at 1,872.25, less than 1% away from a record high close.

Leading the charge to the upside with a 39.3% gain, despite a lack of company-specific news, was clinical-stage cancer-focused biopharmaceutical Geron (NASDAQ: GERN  ) . Despite the gain, Geron still has a long way to go to make up for its 60% nosedive last week after the Food and Drug Administration verbally told the company that it was placing imetelstat on full clinical hold due to the occurrence of persistent low-grade liver function abnormalities in its phase 2 study for polycythemia vera. There are plenty of questions for investors and the FDA right now regarding whether these liver abnormalities are reversible, and if so how that might alter the marketing of imetelstat should it be approved. The experimental therapy certainly delivered exciting results in an investigator-sponsored myelofibrosis trial from the Mayo Clinic, but until we have better clarity on the FDA's decision on imetelstat, investors should probably steer clear of Geron.

Biofuels and bio-based chemicals supplier FutureFuel (NYSE: FF  ) advanced 17.6% after reporting market-topping fourth-quarter results. For the quarter, FutureFuel delivered a 68% increase in revenue to $125.6 million; net income soared 327% to $26.5 million, or $0.61 per share, from just $0.15 per share in the year-ago quarter. By comparison, Wall Street had anticipated an EPS profit of just $0.23. As automakers continue to push their production away from gasoline and toward alternative fuels companies like FutureFuel could continue to see major benefits. Keep in mind that the company has little analyst coverage, so surprises to the upside and downside with regard to EPS are very likely. However, with its dividend boosted by $0.01 per quarter to $0.12 and revenue growth soaring, there's a reasonable shot that shares of FutureFuel could head even higher.

Finally, independent oil and gas exploration and production company Penn Virginia (NYSE: PVA  ) surged 15.6% following a 13D SEC filing in which Soros Fund Management disclosed a 9.18% active stake in the company. In the filing, Soros Fund Management noted that Penn Virginia has done a good job in running its business, but believes that, through meetings with management, it can come up with strategic alternatives to help improve shareholder value. There are a number of ways shareholder value can be improved, from stock buybacks and dividends to a potential sale of part or all of the company. It's uncertain if Soros Fund Management intends to explore any or all of these paths, but with Penn Virginia up more than 300% from its 52-week low and trading at 27 times forward earnings, that optimism may be fully baked into its shares already.

Geron, Penn Virginia, and FutureFuel all soared today -- but all three could have a difficult time keeping pace with this top stock in 2014
There's a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.


Read/Post Comments (0) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2880552, ~/Articles/ArticleHandler.aspx, 9/30/2014 9:58:53 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement